Thursday, March 30, 2017

US FDA News: LaBri’s Body Health Atomic by Envy Me: Recall - Undeclared Drug Ingredient

Sibutramine may substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Read more: LaBri’s Body Health Atomic by Envy Me: Recall - Undeclared Drug Ingredient